{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:26:50Z","timestamp":1773948410733,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.vaccine.2022.07.013","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T02:29:49Z","timestamp":1658111389000},"page":"4929-4932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern"],"prefix":"10.1016","volume":"40","author":[{"given":"Christopher L.D.","family":"McMillan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto A.","family":"Amarilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naphak","family":"Modhiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovin J.Y.","family":"Choo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armira","family":"Azuar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate E.","family":"Honeyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander A.","family":"Khromykh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Watterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2022.07.013_b0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15585\/mmwr.mm7106a4","article-title":"Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants \u2014 United States, June 2021\u2013January 2022","volume":"71","author":"Lambrou","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.07.013_b0010","doi-asserted-by":"crossref","unstructured":"Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay JB, et al. Effectiveness of COVID-19 vaccines against Omicron or Delta infection. medRxiv. 2022:2021.12.30.21268565.","DOI":"10.1101\/2021.12.30.21268565"},{"issue":"5","key":"10.1016\/j.vaccine.2022.07.013_b0015","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMc2119270","article-title":"Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa","volume":"386","author":"Collie","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.07.013_b0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMc2119641","article-title":"Plasma Neutralisation of the SARS-CoV-2 Omicron Variant","volume":"386","author":"Schmidt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.07.013_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-04387-1","article-title":"Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralisation","author":"Cele","year":"2021","journal-title":"Nature"},{"issue":"6510","key":"10.1016\/j.vaccine.2022.07.013_b0030","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"issue":"44","key":"10.1016\/j.vaccine.2022.07.013_b0035","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj8065","article-title":"Complete protection by a single-dose skin patch-delivered SARS-CoV-2 spike vaccine","volume":"7","author":"McMillan","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.vaccine.2022.07.013_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.625136","article-title":"An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2","volume":"12","author":"Amarilla","year":"2021","journal-title":"Front Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2022.07.013_b0045","doi-asserted-by":"crossref","first-page":"e13460","DOI":"10.1371\/journal.pone.0013460","article-title":"Skin Vaccination against Cervical Cancer Associated Human Papillomavirus with a Novel Micro-Projection Array in a Mouse Model","volume":"5","author":"Corbett","year":"2010","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2022.07.013_b0050","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2012.01.030","article-title":"Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses","volume":"159","author":"Fernando","year":"2012","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.vaccine.2022.07.013_b0055","doi-asserted-by":"crossref","first-page":"e10266","DOI":"10.1371\/journal.pone.0010266","article-title":"Potent Immunity to Low Doses of Influenza Vaccine by Probabilistic Guided Micro-Targeted Skin Delivery in a Mouse Model","volume":"5","author":"Fernando","year":"2010","journal-title":"PLoS ONE"},{"issue":"26","key":"10.1016\/j.vaccine.2022.07.013_b0060","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1016\/j.vaccine.2018.05.053","article-title":"Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch\u2122)","volume":"36","author":"Fernando","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.07.013_b0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2016.06.045","article-title":"Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8+ T cell responses","volume":"237","author":"Fernando","year":"2016","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.vaccine.2022.07.013_b0070","doi-asserted-by":"crossref","first-page":"e1003024","DOI":"10.1371\/journal.pmed.1003024","article-title":"Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial","volume":"17","author":"Forster","year":"2020","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.vaccine.2022.07.013_b0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/vaccines7040189","article-title":"Efficient Delivery of Dengue Virus Subunit Vaccines to the Skin by Microprojection Arrays","volume":"7","author":"Muller","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2022.07.013_b0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13011-0","article-title":"High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses","volume":"7","author":"Muller","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2022.07.013_b0085","doi-asserted-by":"crossref","DOI":"10.1038\/srep22094","article-title":"Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses","volume":"6","author":"Muller","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2022.07.013_b0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00328-1","article-title":"A chimeric dengue virus vaccine candidate delivered by high density microarray patches protects against infection in mice","volume":"6","author":"Choo","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2022.07.013_b0095","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1056\/NEJMc2119236","article-title":"SARS-CoV-2 Omicron Variant Neutralisation in Serum from Vaccinated and Convalescent Persons","volume":"386","author":"R\u00f6ssler","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2200888X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2200888X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:15:23Z","timestamp":1759403723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2200888X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":19,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0264410X2200888X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.07.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}